manusyriac
☆    

India,
2010-09-28 20:14
(5751 d 00:47 ago)

Posting: # 5945
Views: 4,504
 

 Use of subject samples for trials [Bioanalytics]

Hi Forum Members,

Can we use subject samples which is already analyzed for trials during BA BE analysis to check the method reliability if the respective subject samples gave an abbe-rent results initially. Is this an acceptable practice for a Pivotal study?
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-09-28 20:23
(5751 d 00:38 ago)

@ manusyriac
Posting: # 5946
Views: 3,851
 

 Pharmacokinetic Repeats

Dear Manusyriac,

it depends on the country you are aiming at. In the U.S. and in Canada, it's acceptable to reanalyse samples (so-called 'Pharmacokinetic Repeats' - you have to have an SOP for that; you cannot simply reanalyse samples because you don't like the result), whereas the EMA definitely does not like this (to say it politely). Hint: Search the Forum for 'pharmacokinetic repeat', 'reanalysis', etc.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
manusyriac
☆    

India,
2010-09-29 06:56
(5750 d 14:05 ago)

@ Helmut
Posting: # 5953
Views: 3,979
 

 Pharmacokinetic Repeats

Hi

this is not a pharmacokinetic repeat. they have just reanalysed (from the same vial) the samples which already injected and having an abberent value.

Thanks for your kind reply.

Manu
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-09-29 23:37
(5749 d 21:24 ago)

@ manusyriac
Posting: # 5961
Views: 3,787
 

 Aberrant results

Dear Manu!

❝ they have just reanalysed (from the same vial) the samples which already

❝ injected and having an abberent value.


Define aberrant. If they can track the result down to a documented (!!) reason like faulty i.st.. addition, bad chromatography, equipment failure, etc. - why not? An SOP and an audit rail is mandatory.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
manusyriac
☆    

India,
2010-10-05 18:47
(5744 d 02:14 ago)

@ Helmut
Posting: # 6002
Views: 3,746
 

 Aberrant results

Hi HS

The respective sample was a suspected mix up with the quality control sample and picked as a repeat as per the SOP. But before repeating the respective sample they reinjected from the same vial to confirm the unusal result under a test folder which is different from the study folder.

My question is since the particular sample is showing an unusual result and already picked for a repeat, reinjecting the same sample from the same vial to confirm the result is an acceptable practice or not. hope this will be clear enough to understand the issue.

Thanks
Manu
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
348 visitors (0 registered, 348 guests [including 25 identified bots]).
Forum time: 21:02 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5